CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
Title: CRISPR/Cas-mediated APOC3 Knockout as a One-time Treatment for Severe Hypertriglyceridemia Presenters: Alan Brooks, PhD, Senior Vice President of Research at Metagenomi Date/time: Monday, ...